Olanzapine-induced Weight Gain: An Animal Model

Introduction: Using an animal model, we examined weight gain in rats exposed to olanzapine, as well as whether increased weight was associated with food intake, visceral fat and/or locomotion. Methods: Sprague-Dawley rats were chronically treated with olanzapine while being offered diets including s...

Full description

Bibliographic Details
Main Author: Mann, Stephen Wallace
Other Authors: Remington, Gary
Language:en_ca
Published: 2009
Subjects:
Online Access:http://hdl.handle.net/1807/18900
id ndltd-TORONTO-oai-tspace.library.utoronto.ca-1807-18900
record_format oai_dc
spelling ndltd-TORONTO-oai-tspace.library.utoronto.ca-1807-189002013-04-19T19:59:13ZOlanzapine-induced Weight Gain: An Animal ModelMann, Stephen Wallaceolanzapineweight gainfood intakelocomotor activity0347Introduction: Using an animal model, we examined weight gain in rats exposed to olanzapine, as well as whether increased weight was associated with food intake, visceral fat and/or locomotion. Methods: Sprague-Dawley rats were chronically treated with olanzapine while being offered diets including standard chow, a high fat (60% fat) diet, and a high fat/high carbohydrate (42% fat; 42.7% carbohydrate) diet. Body weight, food intake, visceral fat and locomotor activity were measured. Results: Our findings related to weight gain are in line with other reports indicating that while olanzapine-induced weight gain can be observed, it does not mirror what is observed in humans on two levels: (i) it is not of the same magnitude, and (ii) it is more gender specific i.e., females greater than males. Conclusions: These data confirm that chronic treatment with olanzapine has varying effects on weight gain, food intake, visceral fat and locomotor activity.Remington, Gary2009-112010-02-15T20:37:40ZNO_RESTRICTION2010-02-15T20:37:40Z2010-02-15T20:37:40ZThesishttp://hdl.handle.net/1807/18900en_ca
collection NDLTD
language en_ca
sources NDLTD
topic olanzapine
weight gain
food intake
locomotor activity
0347
spellingShingle olanzapine
weight gain
food intake
locomotor activity
0347
Mann, Stephen Wallace
Olanzapine-induced Weight Gain: An Animal Model
description Introduction: Using an animal model, we examined weight gain in rats exposed to olanzapine, as well as whether increased weight was associated with food intake, visceral fat and/or locomotion. Methods: Sprague-Dawley rats were chronically treated with olanzapine while being offered diets including standard chow, a high fat (60% fat) diet, and a high fat/high carbohydrate (42% fat; 42.7% carbohydrate) diet. Body weight, food intake, visceral fat and locomotor activity were measured. Results: Our findings related to weight gain are in line with other reports indicating that while olanzapine-induced weight gain can be observed, it does not mirror what is observed in humans on two levels: (i) it is not of the same magnitude, and (ii) it is more gender specific i.e., females greater than males. Conclusions: These data confirm that chronic treatment with olanzapine has varying effects on weight gain, food intake, visceral fat and locomotor activity.
author2 Remington, Gary
author_facet Remington, Gary
Mann, Stephen Wallace
author Mann, Stephen Wallace
author_sort Mann, Stephen Wallace
title Olanzapine-induced Weight Gain: An Animal Model
title_short Olanzapine-induced Weight Gain: An Animal Model
title_full Olanzapine-induced Weight Gain: An Animal Model
title_fullStr Olanzapine-induced Weight Gain: An Animal Model
title_full_unstemmed Olanzapine-induced Weight Gain: An Animal Model
title_sort olanzapine-induced weight gain: an animal model
publishDate 2009
url http://hdl.handle.net/1807/18900
work_keys_str_mv AT mannstephenwallace olanzapineinducedweightgainananimalmodel
_version_ 1716582003389759488